April 2014
Volume 55, Issue 13
Free
ARVO Annual Meeting Abstract  |   April 2014
Outcomes of Combined subconjunctival with subscleral Ologen implant in glaucoma filtering surgery
Author Affiliations & Notes
  • Dewang Angmo
    Ophthalmology, Dr RP Centre for Ophthalmic Sciences, AIIMS, New Delhi, India
  • Ruchita Falera
    Ophthalmology, Dr RP Centre for Ophthalmic Sciences, AIIMS, New Delhi, India
  • Archita Singh
    Ophthalmology, Dr RP Centre for Ophthalmic Sciences, AIIMS, New Delhi, India
  • Gautam Sinha
    Ophthalmology, Dr RP Centre for Ophthalmic Sciences, AIIMS, New Delhi, India
  • Bharat Patil
    Ophthalmology, Dr RP Centre for Ophthalmic Sciences, AIIMS, New Delhi, India
  • Tanuj Dada
    Ophthalmology, Dr RP Centre for Ophthalmic Sciences, AIIMS, New Delhi, India
  • Footnotes
    Commercial Relationships Dewang Angmo, None; Ruchita Falera, None; Archita Singh, None; Gautam Sinha, None; Bharat Patil, None; Tanuj Dada, None
  • Footnotes
    Support None
Investigative Ophthalmology & Visual Science April 2014, Vol.55, 3165. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      Dewang Angmo, Ruchita Falera, Archita Singh, Gautam Sinha, Bharat Patil, Tanuj Dada; Outcomes of Combined subconjunctival with subscleral Ologen implant in glaucoma filtering surgery. Invest. Ophthalmol. Vis. Sci. 2014;55(13):3165.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Purpose: To evaluate the efficacy of Combined subconjunctival with subscleral Ologen implantation in glaucoma filtering surgery.

Methods: 15 eyes of 15 patients underwent fornix based trabeculectomy with insertion of ologen implant both subsclerally and subconjunctivally (double ologen) without the use of Mitomycin-C/5-Flurouracil. All patients had a minimum of 12 months follow up. Pre-operative data and post-operative data at 1 week, 1 month, 3 months, 6months and thereafter every 6 months for BCVA, applanation tonometry, bleb morphology & leaks, lens status, antiglaucoma medications, perimetry & any complications were noted.

Results: The average age of patients was 50.86±14.76yrs (range 18-68 years). The male:female ratio was 10:5. The diagnosis were varied with 3 patients having Juvenile open angle glaucoma, 4 patients with Primary open angle glaucoma, 8 patients with Primary angle closure glaucoma. The mean preoperative IOP was 40.67±7.88mmHg. The average follow up was 18.5±4.7mths, with a minimum of at least 12mths. Postoperatively, the IOP at 3mths was 11.13±2.74mmHg; 6mths was 12.11±2.14mmHg; 12mths was 13.33±2.69mmHg. All patients had IOP≤18mmHg with no additional antiglaucoma medications. The preoperative & postoperative BCVA in LogMAR was 0.25±0.21 and 0.28±0.22 (p=0.239). 2 patients had shallow anterior chamber in the initial postoperative day, which was reformed and subsequently patients did well. 1 patient had choroidal detachment and one patient required resutring of conjunctiva in initial postoperative days.

Conclusions: Trabeculectomy with implantation of Ologen implant both subsclerally and subconjunctivally appears to offer encouraging short-term results in terms of IOP control in eyes with primary adult glaucoma.

Keywords: 462 clinical (human) or epidemiologic studies: outcomes/complications • 765 wound healing  
×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×